About
Technology
Issues
FAQ
Links
Official Page
ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA <500000 Copies/mL
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.